English
Bulgarian
Chinese (Simplified)
Croatian
Czech
Danish
Dutch
Finnish
French
German
Greek
Hebrew
Hindi
Indonesian
Italian
Japanese
Korean
Macedonian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swedish
Thai
Turkish
Vietnamese
News
The 2020 iCMLf Prize is awarded to Dr Sabira Kurtovic (Bosnia and Herzegovina)
March 2020 - The iCMLf awards the 2020 iCMLf Prize to Dr Sabira Kurtovic, a hematologist at the Clinical Centre of the University of Sarajevo, Bosnia and Herzegovina.
This iCMLf Prize recognises outstanding contributions to the improvement of CML treatment under the challenging conditions of low- and middle-income countries with unequal access to monitoring and treatment. Dr Kurtovic is awarded the iCMLf Prize for her tireless work to ensure that patients with CML in Bosnia and Herzegovina receive the best possible care and have access to treatment with tyrosine kinase inhibitors (TKIs).
"I am thrilled and delighted that Dr Kurtovic will receive the 2020 iCMLf Prize. She has demonstrated a humanitarian spirit and drive through war and beyond, managing always to keep patient welfare at the forefront. Having worked with her I know first hand her dedication, intelligence, and compassion."
(Professor Jerry Radich, Fred Hutchinson Cancer Research Centre)
The 2020 iCMLf Goldman Prize is awarded to Professor Jane Apperley
March 2020 - The iCMLf is pleased to announce the winner of the 2020 Goldman Prize. Professor Jane Apperley, Chair of the Centre for Haematology at Imperial College, London, UK will receive her Goldman medal during the 2020 John Goldman meeting on CML in October. The annual Goldman Prize, awarded in honour of Professor John Goldman, acknowledges outstanding contributions to the management of patients with CML. Professor Apperley receives the prize in recognition of her exceptional reputation as a clinical academic and her many years of expertise in CML and blood and bone marrow transplantation.
"Jane has been one of the leaders in CML research for many years. She has helped us not only develop better therapies for patients with CML, but with thorough, thoughtful and innovative research and analysis, understand the best way to manage patients incorporating all known variables and even helping us think of new variables that play a role. She has always kept a critical but balanced view of the data and performed innovative and groundbreaking research. Jane and her group have been leaders in CML research for many years and her contributions make her a very deserving recipient of this award. And even more fitting having worked with John for so many years.”
(Professor Jorge Cortes, Georgia Cancer Center, Augusta University)
February 29th is Rare Disease Day!
February 2020 - Today we join many other organizations supporting rare diseases and patients all over the world to raise awareness for rare diseases. There are over 300 million people living with a rare disease worldwide.
With an incidence of between 1 and 2 people per 100,000 people annually, CML is a rare disease making it even harder for patients living with CML in low- and middle-income countries to be heard and to get access to appropriate monitoring and treatment.
The 2020 iCMLf Rowley Prize is awarded to Professor Ravi Bhatia
March 2020 - We are delighted to announce that this year Professor Ravi Bhatia, Director of the University of Alabama Division of Hematology-Oncology and Deputy Director of the O’Neal Comprehensive Cancer Center at the University of Alabama in Birmingham, USA, joins the long line of internationally renowned scientists awarded the iCMLf Rowley Prize. This annual prize awarded by the International CML Foundation recognises outstanding contributions to the understanding of the biology of CML.
‘Ravi Bhatia is a global leader in leukemia research who has made fundamental discoveries about the nature of the leukemic stem cell in CML. These discoveries are leading to promising therapeutic developments. He is also a generous and inspirational mentor and educator. Ravi is a very worthy winner of the Rowley Prize for 2020.’
(Timothy Hughes, Chairman of the iCMLf)
Create a future without cancer - February 4 is World Cancer Day
February 2020 - Today is World Cancer Day. I can and I will.
“Somebody has to make the change. It starts with me. I am creating awareness.”
(Andy Ojelabi, Nigeria)
Andy –a CML patient from Nigeria climbed Mount Kilimanjaro with us to raise awareness on CML and to raise funds for the iCMLf CURE Program.
Nominate for the 2020 iCMLf prizes
December 2019 - Great progress has been made for patients with CML in recent years, but there are still many challenges to meet. Scientists and clinicians around the world continue to work hard to drive research in CML and to find a cure for CML.
We continue with our tradition to recognise and reward these personal contributions and outstanding achievements to our understanding of the biology of CML and to improving the management of patients with CML around the world.
Since the first iCMLf Rowley Prize was awarded to Professor Brian Druker in 2009, we have honoured 23 well-deserved award winners with the three specific iCMLf Prizes.
Who will be next? You are now welcome to nominate a colleague, or mentor for one of the 2020 prizes.
